These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20969748)

  • 21. Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis.
    Espinosa I; Catasus L; Canet B; D'Angelo E; Muñoz J; Prat J
    Mod Pathol; 2011 Jun; 24(6):846-54. PubMed ID: 21317880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
    Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S
    Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differential expression of USP2, USP14 and UBE4A between ovarian serous cystadenocarcinoma and adjacent normal tissues].
    Yang Y; Hou JQ; Qu LY; Wang GQ; Ju HW; Zhao ZW; Yu ZH; Yang HJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):504-6. PubMed ID: 17553343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression patterns that characterize advanced stage serous ovarian cancers.
    Lancaster JM; Dressman HK; Whitaker RS; Havrilesky L; Gray J; Marks JR; Nevins JR; Berchuck A
    J Soc Gynecol Investig; 2004 Jan; 11(1):51-9. PubMed ID: 14706684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer.
    Li M; Cheng X; Rong R; Gao Y; Tang X; Chen Y
    BMC Cancer; 2020 Oct; 20(1):1032. PubMed ID: 33109151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma.
    Khalifeh I; Munkarah AR; Schimp V; Morris R; Lawrence WD; Ali-Fehmi R
    Int J Gynecol Pathol; 2005 Jul; 24(3):228-34. PubMed ID: 15968197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival.
    Choi CH; Choi JJ; Park YA; Lee YY; Song SY; Sung CO; Song T; Kim MK; Kim TJ; Lee JW; Kim HJ; Bae DS; Kim BG
    Br J Cancer; 2012 Jun; 107(1):91-9. PubMed ID: 22644307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CST2 promotes cell proliferation and regulates cell cycle by activating Wnt-β-catenin signalling pathway in serous ovarian cancer.
    Wang X; Zhao S; Guo Y; Wang C; Han S; Wang X
    J Obstet Gynaecol; 2024 Dec; 44(1):2363515. PubMed ID: 38864487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact on high-grade serous ovarian cancer of obesity and lipid metabolism-related gene expression patterns: the underestimated driving force affecting prognosis.
    Cuello MA; Kato S; Liberona F
    J Cell Mol Med; 2018 Mar; 22(3):1805-1815. PubMed ID: 29266765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA expression profiles in serous ovarian carcinoma.
    Nam EJ; Yoon H; Kim SW; Kim H; Kim YT; Kim JH; Kim JW; Kim S
    Clin Cancer Res; 2008 May; 14(9):2690-5. PubMed ID: 18451233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.
    Callahan MJ; Nagymanyoki Z; Bonome T; Johnson ME; Litkouhi B; Sullivan EH; Hirsch MS; Matulonis UA; Liu J; Birrer MJ; Berkowitz RS; Mok SC
    Clin Cancer Res; 2008 Dec; 14(23):7667-73. PubMed ID: 19047092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification by cDNA microarray of genes involved in ovarian carcinogenesis.
    Ono K; Tanaka T; Tsunoda T; Kitahara O; Kihara C; Okamoto A; Ochiai K; Takagi T; Nakamura Y
    Cancer Res; 2000 Sep; 60(18):5007-11. PubMed ID: 11016619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
    Donninger H; Bonome T; Radonovich M; Pise-Masison CA; Brady J; Shih JH; Barrett JC; Birrer MJ
    Oncogene; 2004 Oct; 23(49):8065-77. PubMed ID: 15361855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
    Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and clinical significance of ELOVL6 gene in high-grade serous ovarian carcinoma].
    Li FJ; Wang HY; Feng XL; Li PP; Shu T; Zhao XH; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):192-7. PubMed ID: 27030498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.